[Medical News & Daily Bosa – By In-Kyu Oh] The signals of the mind, which were once unnoticed, can now be objectively analyzed and provided as numerical data, thanks to the development of commercialization technology based on biological signals. Medical professionals are leading the way in making this possible.
Developed by BWAVE Inc., the iMindwave Mini utilizes heart rate variability (Photoplethysmograph, PPG) and artificial intelligence (AI) to analyze and assess users’ mental well-being based on biological signals.
Enet News – BWAVE Inc. (CEO Seung-Hwan Lee), an AI-based mental health care company, announced on the 26th that it has signed a Memorandum of Understanding (MOU) with Neurosona Inc. (CEO Sun-Il Seo), a specialized developer of low-intensity focused ultrasound (LIFU) electronic drugs for brain disease
BWAVE Signs MOU with DolbomDream to Develop AI-Based Mental Health Assessment and Diagnostic Service
G-Valley News, Reporter Seon-Mi Yoon – AI-based mental health healthcare company BWAVE announced on the 20th that it signed a Memorandum of Understanding (MOU) with mental healthcare company DolbomDream on the 10th to develop an AI-based mental health assessment and diagnostic service using biometric signals.